推荐产品
生物源
mouse
品質等級
抗體表格
ascites fluid
抗體產品種類
primary antibodies
無性繁殖
133-1H, monoclonal
物種活性
human
製造商/商標名
Chemicon®
技術
ELISA: suitable
immunofluorescence: suitable
同型
IgG2a
運輸包裝
wet ice
一般說明
RSV是一种不稳定的副粘病毒,在组织培养中产生人类细胞的特征性融合-合胞体效应。已经鉴定出两种亚型A和B。亚型B的特征是该病毒的无症状株。更严重的临床疾病涉及亚型A株。
特異性
针对RSV的47-49 kDa融合蛋白。 抗体MAB858-1可识别A和B RSV株。
免疫原
A2
表位:所有A & B型株
應用
ELISA(1:800+)
间接免疫荧光(1:100-200+)(新鲜冷冻组织切片)
最终工作稀释度必须由最终用户确定。
间接免疫荧光(1:100-200+)(新鲜冷冻组织切片)
最终工作稀释度必须由最终用户确定。
研究子类别
传染病 - 病毒
传染病 - 病毒
研究类别
传染病
传染病
该抗RSV抗体,融合蛋白,所有A、B型毒株,克隆133-1H,经验证可用于ELISA、IF检测呼吸道合胞病毒。
外觀
未纯化
腹水,0.1%叠氮化钠作为防腐剂。
儲存和穩定性
自收到之日起在-20°C可稳定保存1年。分装保存以避免反复冻融。为了最大程度地回收产品,需在融化后和取下盖子之前将原始样品管进行离心。
分析報告
对照
RSV对照玻片,目录号5012-5
RSV对照玻片,目录号5012-5
其他說明
浓度:关于批次特定浓度请参见检验报告。
法律資訊
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
免責聲明
除非我们的目录或产品随附的其他公司文件中另有说明,否则我们的产品预期仅用于研究用途,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或对人类或动物的任何类型的消费或应用。
Not finding the right product?
Try our 产品选型工具.
儲存類別代碼
12 - Non Combustible Liquids
水污染物質分類(WGK)
nwg
閃點(°C)
Not applicable
Molecules and cells, 12(1), 50-56 (2001-09-20)
Respiratory syncytial virus (RSV) is one of the principal agents of bronchiolitis and pneumonia in young children. Thus, there is a strong need to make a safe and effective vaccine against the RSV infection. DNA immunization is very effective at
Journal of virology, 90(1), 206-221 (2015-10-16)
It is well established that influenza A virus (IAV) attachment to and infection of epithelial cells is dependent on sialic acid (SIA) at the cell surface, although the specific receptors that mediate IAV entry have not been defined and multiple
Nature communications, 14(1), 4347-4347 (2023-07-20)
Nirsevimab is a monoclonal antibody that binds to the respiratory syncytial virus (RSV) fusion protein. During the Phase 2b (NCT02878330) and MELODY (NCT03979313) clinical trials, infants received one dose of nirsevimab or placebo before their first RSV season. In this
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 39(2), 119-124 (2007-04-25)
Human respiratory syncytial virus (hRSV) detection in nasopharyngeal aspirates (NPAs) from infants with acute respiratory tract infection (ARTI) does not prove the hRSV etiology of the current ARTI episode. HRSV RNA quantification may help in affording this issue. hRSV was
EMBO molecular medicine, 6(11), 1436-1454 (2014-10-10)
Infections with human respiratory syncytial virus (HRSV) occur globally in all age groups and can have devastating consequences in young infants. We demonstrate that a vaccine based on the extracellular domain (SHe) of the small hydrophobic (SH) protein of HRSV
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门